港股異動 | 眾安在線升超5%創10個月新高 2019年保費增收超3成
格隆匯1月17日丨眾安在線(6060.HK)午後股價拉昇明顯,現漲5.32%,報31.7港元盤中創10個月新高,暫成交3.2億港元,最新總市值465.9億港元。眾安在線(06060.HK)日前發佈公告,公司2019年所獲得的原保險保費收入總額約為人民幣146.35億元,同比增長30.4%。值得注意的是,日前公司股價被股東鄭方減持13.5萬股,涉資約383.07萬港元。12月初,摩根大通大升公司目標價至32港元,升至增持評級。推動股價上升的因素包括其業務重點轉移至輕資產業務,如健保及網上銷售渠道。預計明年綜合成本率可降至100%以下水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.